Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

David Einhorn’s Top Stocks Dominate the Market Even Though Greenlight Capital Doesn’t

Over at Institutional Investor’s Alpha, Stephen Taub wrote an article with the following headline: “David Einhorn’s Greenlight Capital Mostly Flat in September.” In Taub’s analysis, he mentions that Einhorn’s hedge fund returned just 0.5% in September. By comparison the S&P 500 ETF was up 3.2% last month, and NASDAQ-tracking ETFs were up near the 5% mark. In addition to falling behind in September, Taub reports that Einhorn and his fund returned 12.2% for the first three quarters of 2013, which is 5.7 percentage points below the return of the S&P 500 index.

David Einhorn

In his last 13F filing with the SEC, Einhorn’s top five positions accounted for roughly 53% of the entire value of his $5.3 billion equity portfolio. The top five were (along with their position size at the end of last quarter, September and YTD returns):

1. Apple Inc. (NASDAQ:AAPL): $950.7M/-2.4% return in September/-13.2% return YTD

2. General Motors (NYSE:GM): $567.8M/+5.4% return in September/+23.5% return YTD

3. Marvell Technology (NASDAQ:MRVL): $518.6M/-6.2% return in September/+55.6% return YTD

4. Aetna (NYSE:AET): $427.5M/+0.4% return in September/+38.4% return YTD

5. Cigna Corp (NYSE:CI): $360.5M/-3.3% return in September/+39.3% return YTD

As you can see, the only stock in Einhorn’s top five with a negative year-to-date return is Apple, and the other four have all had exceptional years. September returns have been spottier, but for Einhorn’s investors, it’s really only the longer-term returns that matter.

For piggybackers, any investor who invested an equal amount of money into each of Einhorn’s top picks since the start of the year is up 28.7%, beating the market by almost 11 percentage points. If you would have placed your bets on Einhorn’s top five according to portfolio weight, your return would be a little less because of Apple’s sheer size (it accounts for almost one-fifth of all equity holdings), but you’d still be up about 21% on the year.

Recommended reading:

Hedge Fund Research

What Are Hedge Funds?

The Top 10 Hedge Funds

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!